Evidence map›Paper›PMID 38702125›Full record

ArticleMayo Clinic proceedings2024

Prescription Opioids and Brain Structure in Community-Dwelling Older Adults.

Nafisseh S Warner, Andrew C Hanson, Phillip J Schulte, Firat Kara, Robert I Reid, Christopher G Schwarz, Eduardo E Benarroch, Jonathan Graff-Radford, Prashanthi Vemuri, Clifford R Jack and 4 more

Abstract read
In one paragraph

Article in Mayo Clinic proceedings, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Nafisseh S WarnerDepartment of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, MN. Electronic address: warner.nafisseh@mayo.edu.
Andrew C HansonDepartment of Health Sciences Research, Mayo Clinic, Rochester, MN.
Phillip J SchulteDepartment of Health Sciences Research, Mayo Clinic, Rochester, MN.
Firat KaraDepartment of Radiology, Mayo Clinic, Rochester, MN.
Robert I ReidDepartment of Radiology, Mayo Clinic, Rochester, MN.
Christopher G SchwarzDepartment of Radiology, Mayo Clinic, Rochester, MN.
Eduardo E BenarrochDepartment of Neurology, Mayo Clinic, Rochester, MN.
Jonathan Graff-RadfordDepartment of Neurology, Mayo Clinic, Rochester, MN.
Prashanthi VemuriDepartment of Radiology, Mayo Clinic, Rochester, MN.
Clifford R JackDepartment of Radiology, Mayo Clinic, Rochester, MN.
Ronald C PetersenDepartment of Neurology, Mayo Clinic, Rochester, MN.
David O WarnerDepartment of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, MN.
Michelle M MielkeDepartment of Epidemiology and Prevention, Wake Forest University School of Medicine, Winston-Salem, NC.
Kejal KantarciDepartment of Radiology, Mayo Clinic, Rochester, MN.

Funding

Interdisciplinary Infrastructure for Aging Research: Rochester Epidemiology ProjectR33AG058738 · NIA · MAYO CLINIC ROCHESTER · PI LEBRASSEUR, NATHAN K, OLSON, JANET E · 2020 to 2022
$2.4M
Prescription opioids, cognitive decline, and Alzheimer's disease in older adultsK23AG070113 · NIA · MAYO CLINIC ROCHESTER · PI WARNER, NAFISSEH S · 2021 to 2025
$818k
Interdisciplinary Infrastructure for Aging Research: Rochester Epidemiology ProjectR21AG058738 · NIA · MAYO CLINIC ROCHESTER · PI LEBRASSEUR, NATHAN K, OLSON, JANET E · 2018 to 2019
$437k
NIA NIH HHS K23 AG070113NIA NIH HHS R21 AG058738NIA NIH HHS R33 AG058738
6 · The paper itself

Abstract

objectiveTo evaluate the associations between prescription opioid exposures in community-dwelling older adults and gray and white matter structure by magnetic resonance imaging.

methodsSecondary analysis was conducted of a prospective, longitudinal population-based cohort study employing cross-sectional imaging of older adult (≥65 years) enrollees between November 1, 2004, and December 31, 2017. Gray matter outcomes included cortical thickness in 41 structures and subcortical volumes in 6 structures. White matter outcomes included fractional anisotropy in 40 tracts and global white matter hyperintensity volumes. The primary exposure was prescription opioid availability expressed as the per-year rate of opioid days preceding magnetic resonance imaging, with a secondary exposure of per-year total morphine milligram equivalents (MME). Multivariable models assessed associations between opioid exposures and brain structures.

resultsThe study included 2185 participants; median (interquartile range) age was 80 (75 to 85) years, 47% were women, and 1246 (57%) received opioids. No significant associations were found between opioids and gray matter. Increased opioid days and MME were associated with decreased white matter fractional anisotropy in 15 (38%) and 16 (40%) regions, respectively, including the corpus callosum, posterior thalamic radiation, and anterior limb of the internal capsule, among others. Opioid days and MME were also associated with greater white matter hyperintensity volume (1.02 [95% CI, 1.002 to 1.036; P=.029] and 1.01 [1.001 to 1.024; P=.032] increase in the geometric mean, respectively).

conclusionThe duration and dose of prescription opioids were associated with decreased white matter integrity but not with gray matter structure. Future studies with longitudinal imaging and clinical correlation are warranted to further evaluate these relationships.

Indexed as

Analgesics, OpioidIndependent LivingMagnetic Resonance ImagingAgedAged, 80 and overBrainCross-Sectional StudiesFemaleGray MatterHumansLongitudinal StudiesMaleProspective StudiesWhite MatterAnalgesics, Opioid

Identifiers

PMID38702125
PMCPMC11081533

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.